Platelet Rich Plasma on Rotator Cuff Repair (PRP)

December 2, 2014 updated by: Eduardo Angeli Malavolta, University of Sao Paulo

Platelet Rich Plasma on Arthroscopic Repair of the Complete Rotator Cuff Lesions: a Prospective and Randomized Study

Repair of the rotator cuff has high rates of re-rupture (20-54%), despite good clinical results. Several ways to improve the healing tendon-bone are currently studied, among them the most used is the use of growth factors. The platelet-rich plasma is a source of several growth factors, and is already used in various orthopedic procedures. The aim of this study is to evaluate the effectiveness of platelet-rich plasma in improve tendon-bone healing in arthroscopic rotator cuff repairs.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Rotator cuff repair(RCR) is a procedure widely performed in the shoulder surgery, given the high prevalence of this type of injury in the population. Regardless of the approach employed, the procedure consists of the rehabilitation of the rotator cuff to his bed. Despite the clinical results are highly satisfactory (success rate around 85%), studies using ultrasound and magnetic resonance imaging (MRI) showed a rate of re-rupture after surgery 20 to 54%. These levels of re-injury suggest a sub-optimal healing in the bone-tendon interface.

Attempts to improve the healing in place of the RMR has been extensively studied in the orthopedic literature. One is the use of growth factors (GF), cytokines play an important role in chemotaxis, cell proliferation and differentiation, as well as the synthesis of extracellular matrix, and that theoretically could have beneficial role in tissue repair.

The Platelet-Rich Plasma (PRP) is one of the most studied sources of GF. It is easy to prepare and non-immunogenic (is done with the patient's own blood), and has the further advantage of the presence of several FC (including PDGF, bFGF, TGF-B, VEGF, EGF, CTGF and IGF). This fact is important because the disease have different effects on different receivers during the various stages of healing.

The use of PRP in bone healing has been evaluated in several studies with conflicting results. There are preclinical studies demonstrating the beneficial effect of PRP on tendon and ligament repair. However, there is no published papers showing the effectiveness of the use of PRP on tendon-bone interface.

The aim of this study is to evaluate the effectiveness of PRP in enhancing the healing tendon-bone repair after injury of RC.

Will be operated patients with complete injury (full thickness) of the rotator cuff, divided into two groups randomly. The use of PRP or not will be decided by sealed envelopes, with 20 individuals in each group. The subjects will be assessed pre and postoperatively according to the criteria for the Constant and UCLA and with the help of MRI, being unknown to the evaluators to which group the patient belongs.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • São Paulo, Brazil
        • University of Sao Paulo
      • São Paulo, Brazil, 05403-010
        • University of São Paulo - Orthopedics and traumatology department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Pain or functional deficit in the shoulder to justify surgical intervention;
  • Complete lesion(full thickness) of the supraspinatus tendon resulting from trauma or degenerative confirmed by MRI;
  • Patients skeletally mature, regardless of sex;
  • Signing the consent form.

Exclusion Criteria:

  • Psychiatric disorders;
  • Vascular-nerve lesions affecting the upper limb;
  • Pregnancy;
  • Immature skeleton;
  • Comorbidities unmatched clinically;
  • Osteoarthritis of the acromioclavicular joint symptomatic requiring surgical intervention;
  • Glenohumeral arthrosis grades 2, 3 and 4 Samilson and Prieto;
  • Rotator Cuff Arthropathy grades IB, IIA and IIB of Seebauer;
  • Active or recent infection;
  • Neuropathic arthropathy;
  • Previous surgery on the same shoulder operated;
  • Patients with painful pathologies of the cervical spine;
  • Patients diagnosed with fibromyalgia;
  • Patients who do not understand or do not agree with the consent form;
  • Fatty degeneration of the muscles of the MR resonance;
  • Retraction of the tendon greater than 3cm (MRI or intraoperative);
  • Subscapular or Infraspinatus rupture that needs repair (MRI or intraoperative).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rotator cuff repair plus PRP
Conventional arthroscopic repair of rotator cuff with application of PRP.
Ultra-centrifuged PRP, 40ml, in the liquid way, after portal closure.
Placebo Comparator: Rotator cuff repair alone
Conventional arthroscopic repair of rotator cuff without application of PRP
Ultra-centrifuged PRP, 40ml, in the liquid way, after portal closure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
UCLA Score
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Constant Scores and Re-tear rate (MRI)
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Eduardo A Malavolta, MD, University of Sao Paulo - Orthopedic and Traumatology Department
  • Study Director: Arnaldo A Ferreira Neto, PhD, University of Sao Paulo - Orthopedic and Traumatology Department

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2008

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

December 9, 2009

First Submitted That Met QC Criteria

December 9, 2009

First Posted (Estimate)

December 10, 2009

Study Record Updates

Last Update Posted (Estimate)

December 3, 2014

Last Update Submitted That Met QC Criteria

December 2, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rotator Cuff Tears

Clinical Trials on Platelet rich plasma

3
Subscribe